AMPK and O-GlcNAcylation: interplay in cardiac pathologies and heart failure

Area of Science:

• Biochemistry
• Cardiology
• Molecular Biology

Background:

• Heart failure (HF) is a significant global health issue with high morbidity and mortality.
• Despite medical advances, understanding HF pathogenesis at the molecular level is crucial.
• AMP-activated protein kinase (AMPK) and O-GlcNAcylation are implicated in cellular energy regulation.

Purpose of the Study:

• To review the roles of AMPK and O-GlcNAcylation in heart failure.
• To elucidate the interplay and dysregulation of these pathways in HF.
• To highlight therapeutic strategies targeting AMPK and O-GlcNAcylation in HF.

Main Methods:

• Comprehensive literature review of preclinical and clinical studies.
• Analysis of molecular mechanisms involving AMPK and O-GlcNAcylation in cardiac function.
• Examination of signalling pathways related to cardiac energetics, metabolism, and remodelling.

Main Results:

• AMPK and O-GlcNAcylation are key regulators of cardiac metabolism and energetics.
• Dysregulation of these pathways contributes to the progression of heart failure.
• Targeting AMPK and O-GlcNAcylation shows potential for novel HF therapies.

Conclusions:

• AMPK and O-GlcNAcylation pathways are critically involved in heart failure pathogenesis.
• Understanding their intricate mechanisms offers new therapeutic avenues for HF.
• Further research into these molecular targets may improve HF management.